STOCK TITAN

Jupiter Acquisition Corporation - JAQC STOCK NEWS

Welcome to our dedicated page for Jupiter Acquisition Corporation news (Ticker: JAQC), a resource for investors and traders seeking the latest updates and insights on Jupiter Acquisition Corporation stock.

Jupiter Acquisition Corporation (NASDAQ: JAQC) is a special purpose acquisition company (SPAC) based in Hobe Sound, FL. It is focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. As a SPAC, Jupiter Acquisition Corporation operates with the intent to identify and partner with promising companies to bring them to the public market and drive growth.

Recently, Jupiter announced its plans to convene and then adjourn its special meeting of stockholders initially scheduled for December 5, 2023, moving it to December 12, 2023. This meeting, to be held virtually via live webcast, will ask stockholders to vote on proposals related to the proposed business combination with Filament Health Corp, a corporation based in British Columbia. The definitive proxy statement and prospectus for this transaction were filed with the SEC on November 13, 2023.

The proposed merger between Jupiter and Filament Health Corp. signifies a strategic move to enhance shareholder value by combining resources and leveraging synergies. Filament Health Corp. is known for its innovative approach in the health sector, and this merger is expected to bolster its market presence and operational capabilities.

Jupiter is led by Chairman and CEO James N. Hauslein, who brings a wealth of experience in managing and growing businesses. The company is known for its disciplined investment approach and dedication to creating long-term value for its shareholders.

For more details on the proposed business combination and other corporate actions, stakeholders are encouraged to refer to the official filings and announcements made by Jupiter Acquisition Corporation.

Rhea-AI Summary
Jupiter Acquisition Corporation (NASDAQ:JAQC) has announced the termination of a business combination agreement with Filament Health Corp. All outstanding shares of its Class A common stock issued as part of the units sold in Jupiter's initial public offering will be redeemed. The per-share redemption price for the public shares is expected to be approximately $10.34. Jupiter's initial stockholders have agreed to waive their redemption rights with respect to certain shares of Class A common stock.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.96%
Tags
-
Rhea-AI Summary
Jupiter Acquisition Corporation (NASDAQ:JAQC) intends to reconvene and adjourn the special meeting of stockholders to vote on the Proposed Business Combination with Filament Health Corp. The meeting will be completely virtual and conducted via live webcast. Stockholders who submitted public shares for redemption will be redeemed if Jupiter implements the proposed extension of time to complete an initial business combination.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.12%
Tags
-
Rhea-AI Summary
Jupiter Acquisition Corporation (NASDAQ:JAQC) intends to adjourn the special meeting of stockholders scheduled for December 5, 2023, to December 12, 2023, to vote on the Proposed Business Combination with Filament Health Corp.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.84%
Tags
Rhea-AI Summary

Jupiter Acquisition Corporation (NASDAQ: JAQCU) has announced that holders of its IPO units can separately trade Class A common stock and warrants starting October 1, 2021. The Class A common stock will trade under the symbol 'JAQC', while the warrants will be under 'JAQCW'. The company, a blank check firm, aims to pursue a business combination within the consumer industry but retains flexibility across sectors. The IPO was initially facilitated by several financial institutions, and relevant registration details are available on the SEC's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Jupiter Acquisition Corporation has successfully closed its initial public offering (IPO), selling 15,000,000 units priced at $10.00 each, raising total gross proceeds of $150,000,000. The units will trade on Nasdaq under the ticker symbol “JAQCU.” Each unit comprises one share of Class A common stock and one-half of a redeemable warrant, with each whole warrant priced at $11.50 per share. The company, a blank check entity, aims to pursue acquisition opportunities primarily in the consumer industry. Underwriters have a 45-day option to buy an additional 2,250,000 units for over-allotments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Jupiter Acquisition Corporation announced the pricing of its IPO at $10.00 per unit, totaling 15,000,000 units. The units will trade under the ticker symbol JAQCU on Nasdaq starting August 13, 2021. Each unit includes one share of Class A common stock and a half warrant, with whole warrants exercisable at $11.50 per share. The offering is expected to close on August 17, 2021, pending customary conditions. The company aims to acquire a business in the consumer industry and is led by notable executives from various investment firms.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags

FAQ

What is the market cap of Jupiter Acquisition Corporation (JAQC)?

The market cap of Jupiter Acquisition Corporation (JAQC) is approximately 62.2M.

What is Jupiter Acquisition Corporation?

Jupiter Acquisition Corporation is a special purpose acquisition company (SPAC) focused on mergers and business combinations to bring companies to the public market.

What recent announcement did Jupiter Acquisition Corporation make?

Jupiter announced the postponement of its special stockholder meeting to December 12, 2023, to vote on the proposed business combination with Filament Health Corp.

Who is leading Jupiter Acquisition Corporation?

James N. Hauslein is the Chairman and CEO of Jupiter Acquisition Corporation.

What is the proposed business combination involving Jupiter?

Jupiter plans to merge with Filament Health Corp., a corporation based in British Columbia, to enhance shareholder value and leverage synergies.

Where can I find more information about Jupiter’s proposed business combination with Filament Health Corp.?

More information can be found in the definitive proxy statement/prospectus filed by Jupiter with the SEC on November 13, 2023.

When and where will the adjourned special meeting take place?

The adjourned special meeting is scheduled to occur on December 12, 2023, at 12:00 p.m. Eastern Time, and will be conducted virtually via live webcast.

What is the strategic significance of the merger with Filament Health Corp.?

The merger is aimed at combining resources and leveraging operational synergies to enhance market presence and shareholder value.

How can shareholders participate in the virtual special meeting?

Shareholders can participate in the virtual special meeting via the live webcast available at https://www.cstproxy.com/jupiteracquisitioncorp/sm2023.

What does a SPAC like Jupiter Acquisition Corporation do?

A SPAC like Jupiter Acquisition Corporation aims to raise capital through an IPO to acquire or merge with an existing company and bring it to the public stock market.

Who should I contact for more information about Jupiter Acquisition Corporation?

For more information, you can contact James N. Hauslein, Chairman and CEO, at jim@hauslein.com or by phone at 212-207-8884.

Jupiter Acquisition Corporation

Nasdaq:JAQC

JAQC Rankings

JAQC Stock Data

62.16M
1.84M
69.45%
23.55%
0.03%
Shell Companies
Financial Services
United States
Hobe Sound